Paper30003189
p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma.
Shimada H. Ann Gastroenterol Surg, 2018. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma. Papers, record 30003189. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30003189
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28795280 | The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan. | Int J Clin Oncol | 2018 | https://conductscience.org/library/papers/28795280 | PubMed |
| 2 | 24479409 | Selective intra-arterial infusion of rAd-p53 with chemotherapy for advanced oral cancer: a randomized clinical trial. | BMC Med | 2014 | https://conductscience.org/library/papers/24479409 | PubMed |
| 3 | 16734736 | Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma. | Cancer Sci | 2006 | https://conductscience.org/library/papers/16734736 | PubMed |
| 4 | 30003189 | p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma. | Ann Gastroenterol Surg | 2018 | https://conductscience.org/library/papers/30003189 | PubMed |
| 5 | 12548611 | Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group. | Cancer | 2003 | https://conductscience.org/library/papers/12548611 | PubMed |
| 6 | 9649454 | Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis. | Gastroenterology | 1998 | https://conductscience.org/library/papers/9649454 | PubMed |
| 7 | 19052812 | Perioperative changes of serum p53 antibody titer is a predictor for survival in patients with esophageal squamous cell carcinoma. | World J Surg | 2009 | https://conductscience.org/library/papers/19052812 | PubMed |
| 8 | 10213922 | Detection of preoperative serum anti-p53 antibodies in gastric cancer. | Tumour Biol | 1999 | https://conductscience.org/library/papers/10213922 | PubMed |
| 9 | 27637603 | The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma. | World J Surg | 2017 | https://conductscience.org/library/papers/27637603 | PubMed |
| 10 | 24241479 | Long-term monitoring of serum p53 antibody after neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: report of a case. | Surg Today | 2014 | https://conductscience.org/library/papers/24241479 | PubMed |
| 11 | 28101684 | p53 Replacement Therapy for Cancer. | Recent Results Cancer Res | 2016 | https://conductscience.org/library/papers/28101684 | PubMed |
| 12 | 23722592 | Randomized, controlled phase II study of post-surgery radiotherapy combined with recombinant adenoviral human p53 gene therapy in treatment of oral cancer. | Cancer Gene Ther | 2013 | https://conductscience.org/library/papers/23722592 | PubMed |
| 13 | 1394236 | p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. | Cancer Res | 1992 | https://conductscience.org/library/papers/1394236 | PubMed |
| 14 | 11495153 | Presence of serum p53 antibodies is associated with decreased in vitro chemosensitivity in patients with esophageal cancer. | Surg Today | 2001 | https://conductscience.org/library/papers/11495153 | PubMed |
| 15 | 15289857 | Growth suppression of esophageal squamous cell carcinoma induced by heavy carbon-ion beams combined with p53 gene transfer. | Int J Oncol | 2004 | https://conductscience.org/library/papers/15289857 | PubMed |
| 16 | 12563234 | Treatment response and prognosis of patients after recurrence of esophageal cancer. | Surgery | 2003 | https://conductscience.org/library/papers/12563234 | PubMed |
| 17 | 11042560 | Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma. | Cancer | 2000 | https://conductscience.org/library/papers/11042560 | PubMed |
| 18 | 22448886 | Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy. | BMC Cancer | 2012 | https://conductscience.org/library/papers/22448886 | PubMed |
| 19 | 28365443 | Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma. | Gastroenterology | 2017 | https://conductscience.org/library/papers/28365443 | PubMed |
| 20 | 26122021 | Germline and somatic genetic predictors of pathological response in neoadjuvant settings of rectal and esophageal cancers: systematic review and meta-analysis. | Pharmacogenomics J | 2016 | https://conductscience.org/library/papers/26122021 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42716804 | Impact of High Immunoreactivity on Surgically Treated Serum p53 Antibody-Positive Esophageal Squamous Cell Carcinoma after Neoadjuvant Therapy: A Multi-Institutional Study of 637 Cases. | Ann Thorac Cardiovasc Surg | 2026 | https://conductscience.org/library/papers/42716804 | PubMed |
| 42645687 | Epidemiological risk factors and inferred p53 pathway dysregulation in Esophageal squamous cell carcinoma in the Somali population. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42645687 | PubMed |
| 41987866 | Prognostic and diagnostic significance of serum p53 antibody levels in patients with surgically treated pancreatic cancer. | Oncol Lett | 2026 | https://conductscience.org/library/papers/41987866 | PubMed |
| 41971943 | Computational Approach Improves Diagnostic Performance Based on Tumor-Associated Autoantibodies in Esophageal Squamous Cell Carcinoma. | Comput Struct Biotechnol J | 2026 | https://conductscience.org/library/papers/41971943 | PubMed |
| 41836060 | Mutant p53 and TP53 mutations in esophageal squamous cell carcinoma: consistency and diagnostic significance. | Front Genet | 2026 | https://conductscience.org/library/papers/41836060 | PubMed |
| 40747232 | Evaluating serum extra spindle pole bodies-like 1 protein vs p53 antibody for hepatitis B virus-related hepatocellular carcinoma diagnosis. | World J Hepatol | 2025 | https://conductscience.org/library/papers/40747232 | PubMed |
| 40607289 | Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study. | Ann Gastroenterol Surg | 2025 | https://conductscience.org/library/papers/40607289 | PubMed |
| 38455491 | Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer. | Ann Gastroenterol Surg | 2024 | https://conductscience.org/library/papers/38455491 | PubMed |
| 38326601 | Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study. | Br J Cancer | 2024 | https://conductscience.org/library/papers/38326601 | PubMed |
| 37693152 | Decoding SEC24 Homolog D, COPII coat complex component accuracy as a signature gene in three human cancers. | Am J Cancer Res | 2023 | https://conductscience.org/library/papers/37693152 | PubMed |
| 36619733 | Gastrointestinal and Pancratohepatobiliary Cancers: A Comprehensive Review on Epidemiology and Risk Factors Worldwide. | Middle East J Dig Dis | 2022 | https://conductscience.org/library/papers/36619733 | PubMed |
| 35832468 | Comparison between a new assay system, Elecsys® Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional study. | Mol Clin Oncol | 2022 | https://conductscience.org/library/papers/35832468 | PubMed |
| 35464847 | Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer. | Front Genet | 2022 | https://conductscience.org/library/papers/35464847 | PubMed |
| 35430563 | Circular RNAs With Efficacy in Preclinical In Vitro and In Vivo Models of Esophageal Squamous Cell Carcinoma. | Cancer Genomics Proteomics | 2022 | https://conductscience.org/library/papers/35430563 | PubMed |
| 35251625 | Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric Cancer. | Mol Clin Oncol | 2022 | https://conductscience.org/library/papers/35251625 | PubMed |
| 34632560 | Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers. | Int J Clin Oncol | 2022 | https://conductscience.org/library/papers/34632560 | PubMed |
| 34504788 | Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer. | Front Oncol | 2021 | https://conductscience.org/library/papers/34504788 | PubMed |
| 34103026 | Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke. | BMC Med | 2021 | https://conductscience.org/library/papers/34103026 | PubMed |
| 33879806 | Urinary microRNA biomarkers for detecting the presence of esophageal cancer. | Sci Rep | 2021 | https://conductscience.org/library/papers/33879806 | PubMed |
| 33790647 | High Expression of MDM2 and the p53 Protein is Predictive Biomarkers for Poor Prognosis of Oesophageal Squamous Cell Carcinoma. | Cancer Manag Res | 2021 | https://conductscience.org/library/papers/33790647 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CEACAM3 | 1084 | PubTator's text mining | https://conductscience.org/library/genes/1084 | NCBI Gene |
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| KRT19 | 3880 | PubTator's text mining | https://conductscience.org/library/genes/3880 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30003189
GET https://conductscience.org/api/papers/v1/30003189/references?page=2